ArticleCurrent oncology (Toronto, Ont.)2023

Initial Experiences of Selective RET Inhibitor Selpercatinib in Adults with Metastatic Differentiated Thyroid Carcinoma and Medullary Thyroid Carcinoma: Real-World Case Series in Korea.

Han-Sang Baek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.